European Archives of Oto-Rhino-Laryngology

, Volume 273, Issue 5, pp 1307–1312 | Cite as

A novel nasopharyngeal stent for the treatment of obstructive sleep apnea: a case series of nasopharyngeal stenting versus continuous positive airway pressure

  • Maximilian Traxdorf
  • Michael Hartl
  • Florian Angerer
  • Christopher Bohr
  • Philipp Grundtner
  • Heinrich Iro
Miscellaneous

Abstract

The objective of the study was to investigate the first-night treatment success of a nasopharyngeal stent compared to standard nCPAP-titration. This is a case series and a single-center study. Eight participants (n = 8) were selected with untreated obstructive sleep apnea with a prestudy AHI ≥10. A newly developed nasopharyngeal stent was tested individually versus standard nCPAP-titration. Cardiorespiratory polysomnography was performed on two consecutive nights (random order: stent, nCPAP). The AHI, the number of obstructive apneas and hypopneas, the mean oxygen saturation, and the minimum oxygen saturation were compared before and after using the nasopharyngeal stent or standard nCPAP. The AHI value before treatment (AHIpre) was 31.1 ± 12.0 (mean ± standard deviation). After inserting the AlaxoStent, the mean AHIstent was 19 ± 12.0 compared to mean AHInCPAP 8.2 ± 11.9 with standard nCPAP-titration. Both nasopharyngeal stenting and nCPAP-titration could reduce the mean number of obstructive apneas by >94 %. Compared to responder rates of classic surgical interventions like uvulopalatopharyngoplasty or multi-level surgery, the nasopharyngeal stent seems to give a comparable responder rate of 50 %. There were no complications associated with the use of the stent and it was well tolerated by all subjects. Nasopharyngeal stenting widens the range of non-invasive mechanical treatment and seems to be an effective mechanical therapeutic alternative to surgery in nCPAP non-compliant patients with OSA. Careful selection of the patient population is a prerequisite of treatment and therefore it should be reserved for individual cases only.

Keywords

Obstructive sleep apnea Nasopharyngeal stent nCPAP incompliance Non-CPAP therapies 

Notes

Acknowledgments

Additional Study investigator: Florian Ruberg MD, Private Practice for Otorhinolaryngology, Neustadt, Germany. Data analysis: Philipp, Grundtner, Department of Otorhinolaryngology, Head and Neck Surgery, University of Erlangen-Nuremberg.

Compliance with ethical statement

Conflict of interest

The authors have no funding, financial relationships, or conflicts of interest to disclose.

Ethical approval

All procedures performed in the study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Doherty LS, Kiely JL, Swan V et al (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127:2076–2084CrossRefPubMedGoogle Scholar
  2. 2.
    Duchna HW (2006) Sleep-related breathing disorders—a second edition of the International Classification of Sleep Disorders (ICSD-2) of the American Academy of Sleep Medicine (AASM). Pneumologie 60:568–575CrossRefPubMedGoogle Scholar
  3. 3.
    Franklin KA, Anttila H, Axelsson S et al (2009) Effects and side-effects of surgery for snoring and obstructive sleep apnea—a systematic review. Sleep 32:27–36PubMedPubMedCentralGoogle Scholar
  4. 4.
    Freuschle A, Heiser C, Maurer JT et al (2013) Treatment of obstructive sleep apnea with the AlaxoStent©. Somnologie 17:212–214CrossRefGoogle Scholar
  5. 5.
    Giles TL, Lasserson TJ, Smith BH et al (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev (3):CD001106Google Scholar
  6. 6.
    Gold AR, Marcus CL, Dipalo F et al (2002) Upper airway collapsibility during sleep in upper airway resistance syndrome. Chest 121:1531–1540CrossRefPubMedGoogle Scholar
  7. 7.
    Iber C, Ancoli-Israel S, Chesson A et al (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, WestchesterGoogle Scholar
  8. 8.
    Isono S (2012) Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology 17:32–42CrossRefPubMedGoogle Scholar
  9. 9.
    Jordan AS, White DP (2008) Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir Physiol Neurobiol 160:1–7CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kushida CA, Chediak A, Berry RB et al (2008) Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med JCSM Off Pub Am Acad Sleep Med 4:157–171Google Scholar
  11. 11.
    Mcardle N, Devereux G, Heidarnejad H et al (1999) Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159:1108–1114CrossRefPubMedGoogle Scholar
  12. 12.
    Nahmias JS, Karetzky MS (1988) Treatment of the obstructive sleep apnea syndrome using a nasopharyngeal tube. Chest 94:1142–1147CrossRefPubMedGoogle Scholar
  13. 13.
    Paulsen FP, Steven P, Tsokos M et al (2002) Upper airway epithelial structural changes in obstructive sleep-disordered breathing. Am J Respir Crit Care Med 166:501–509CrossRefPubMedGoogle Scholar
  14. 14.
    Powell HR, Watson NA, Kotecha BT (2014) Pilot study assessing the efficacy of a novel treatment for sleep related breathing disorders in patients undergoing sleep nasendoscopy. Clin Otolaryngol Off J ENT-UK Off J Neth Soc Otorhinolaryngol Cervicofac SurgGoogle Scholar
  15. 15.
    Randerath WJ, Verbraecken J, Andreas S et al (2011) Non-CPAP therapies in obstructive sleep apnoea. Eur Respir J Off J Eur Soc Clin Respir Physiol 37:1000–1028Google Scholar
  16. 16.
    Ryan CM, Bradley TD (2005) Pathogenesis of obstructive sleep apnea. J Appl Physiol 99:2440–2450CrossRefPubMedGoogle Scholar
  17. 17.
    Sher AE, Schechtman KB, Piccirillo JF (1996) The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 19:156–177PubMedGoogle Scholar
  18. 18.
    Sin DD, Mayers I, Man GC et al (2002) Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 121:430–435CrossRefPubMedGoogle Scholar
  19. 19.
    Sullivan CE, Issa FG (1985) Obstructive sleep apnea. Clin Chest Med 6:633–650PubMedGoogle Scholar
  20. 20.
    Verse T, De La Chaux R, Dreher A et al (2008) Guideline: treatment of adult obstructive sleep apnea. Laryngorhinootologie 87:192–204CrossRefPubMedGoogle Scholar
  21. 21.
    Wozniak DR, Lasserson TJ, Smith I (2014) Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev 1:CD007736PubMedGoogle Scholar
  22. 22.
    Young T, Shahar E, Nieto FJ et al (2002) Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162:893–900CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Maximilian Traxdorf
    • 1
  • Michael Hartl
    • 2
  • Florian Angerer
    • 1
  • Christopher Bohr
    • 1
  • Philipp Grundtner
    • 1
  • Heinrich Iro
    • 1
  1. 1.Department of Otorhinolaryngology, Head and Neck SurgeryUniversity of Erlangen-NurembergErlangenGermany
  2. 2.Private Practice for OtorhinolaryngologyChamGermany

Personalised recommendations